Goldman Sachs Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $13
XP Is Maintained at Neutral by Goldman Sachs
XP Raised to Buy From Neutral by UBS
UBS Upgrades XP to Buy, Lowers Price Target to $16
XP Analyst Ratings
UBS Upgrades XP Inc(XP.US) to Buy Rating, Cuts Target Price to $16
Banco Santander Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $13
XP Inc. Downgraded to Neutral From Outperform at Grupo Santander
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $18
XP Cut to Neutral From Buy by B of A Securities
XP Analyst Ratings
BofA Securities Downgrades XP Inc(XP.US) to Hold Rating, Cuts Target Price to $16
XP Inc. Downgraded to Neutral at BofA Amid Brazil Financial Rating Changes
BofA Securities Downgrades XP to Neutral From Buy, Price Target Is $16
XP Is Maintained at Equal-Weight by Morgan Stanley
XP Analyst Ratings
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $21
UBS Maintains XP Inc(XP.US) With Hold Rating, Cuts Target Price to $19
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24